170 related articles for article (PubMed ID: 30249366)
21. Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.
Rhee SJ; Choi Y; Lee S; Oh J; Kim SJ; Yoon SH; Cho JY; Yu KS
Drug Des Devel Ther; 2016; 10():2525-34. PubMed ID: 27570447
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults.
Jeong SI; Kim Y; Nah JJ; Huh W; Jang IJ; Hwang JG; Lee S
Br J Clin Pharmacol; 2023 Jun; 89(6):1780-1788. PubMed ID: 36496349
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study.
Kim TE; Lim KS; Park MK; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Sep; 34(9):1986-98. PubMed ID: 22943970
[TBL] [Abstract][Full Text] [Related]
25. A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.
Jung CH; Rhee EJ; Lee WY; Min KW; Shivane VK; Sosale AR; Jang HC; Chung CH; Nam-Goong IS;
Diabetes Obes Metab; 2018 Jun; 20(6):1535-1541. PubMed ID: 29436761
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.
Karim A; Covington P; Christopher R; Davenport M; Fleck P; Li X; Wann E; Mekki Q
Int J Clin Pharmacol Ther; 2010 Jan; 48(1):46-58. PubMed ID: 20040339
[TBL] [Abstract][Full Text] [Related]
27. Effect of renal impairment and haemodialysis on the pharmacokinetics of gemigliptin (LC15-0444).
Shon JH; Kim N; Park SJ; Oh MK; Kim EY; Lee SH; Kim YH; Shin JG
Diabetes Obes Metab; 2014 Oct; 16(10):1028-31. PubMed ID: 24641348
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
29. An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men.
Moon SJ; Yu KS; Kim MG
Clin Ther; 2020 Jun; 42(6):1047-1057. PubMed ID: 32362346
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
Cho HY; Yoon H; Lim YC; Lee YB
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.
Li J; Klemm K; O'Farrell AM; Guler HP; Cherrington JM; Schwartz S; Boyea T
Curr Med Res Opin; 2010 Aug; 26(8):2003-10. PubMed ID: 20583949
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
34. A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects.
Kim E; Park KR; Jang IJ; Yu KS; Lee S
Drug Des Devel Ther; 2019; 13():3879-3885. PubMed ID: 32009778
[TBL] [Abstract][Full Text] [Related]
35. Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults.
Nakamaru Y; Hayashi Y; Davies M; Jürgen Heuer H; Hisanaga N; Akimoto K
Clin Ther; 2015 Sep; 37(9):2007-18. PubMed ID: 26212570
[TBL] [Abstract][Full Text] [Related]
36. No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.
Kim YK; Hwang JG; Park MK
Drug Des Devel Ther; 2021; 15():1725-1734. PubMed ID: 33953542
[TBL] [Abstract][Full Text] [Related]
37. Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
Park SE; Lee BW; Kim JH; Lee WJ; Cho JH; Jung CH; Lee SH; Suh S; Hur GC; Kim SH; Jang YH; Park CY;
Diabetes Obes Metab; 2017 Jun; 19(6):892-896. PubMed ID: 28058753
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
[TBL] [Abstract][Full Text] [Related]
39. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
